These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9379499)

  • 1. [Evaluation of liver function in liver diseases using drugs as indicators].
    Tanaka E; Yasuhara H
    J Toxicol Sci; 1997 Aug; 22(3):APP 79-87. PubMed ID: 9379499
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease.
    Tanaka E; Breimer DD
    J Clin Pharm Ther; 1997 Aug; 22(4):237-49. PubMed ID: 9548204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipyrine excretion and aminopyrine breath test: use and significance in the assessment of liver function].
    Gugler R
    Z Gastroenterol; 1987 Mar; 25 Suppl 2():51-6. PubMed ID: 3590907
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation of the hepatocyte.
    Tygstrup N; Vilstrup H
    Lab Res Methods Biol Med; 1983; 7():17-41. PubMed ID: 6353103
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative assessment of deranged hepatic function: a missed opportunity?
    Bircher J
    Semin Liver Dis; 1983 Nov; 3(4):275-84. PubMed ID: 6359423
    [No Abstract]   [Full Text] [Related]  

  • 6. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring hepatic function.
    Zaloga GP; Prough DS
    Crit Care Clin; 1988 Jul; 4(3):591-603. PubMed ID: 3063353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 13C-breath tests in the study of microsomal liver function.
    Nista EC; Fini L; Armuzzi A; Candelli M; Zocco MA; Cazzato IA; Merra G; Finizio R; Miele L; Grieco A; Gasbarrini G; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(1):33-46. PubMed ID: 15209153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antipyrine test in evaluating the detoxifying function of the liver in chronic diseases].
    Loginov AS; Bendikov EA; Otunbaeva DI; Rykova IA; Petrakov AV
    Ter Arkh; 1982; 54(12):31-4. PubMed ID: 6760440
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study and evaluation of liver function with anatomopathological control].
    Leno Valencia L; Matorras Galán P; Ramos Fernández R; Terán Díaz E; Val Bernal F; Garijo Ayensa F; Vidal Sampedro E
    Rev Clin Esp; 1971 Nov; 123(4):335-40. PubMed ID: 5157915
    [No Abstract]   [Full Text] [Related]  

  • 11. [The DMA test can be used as a clinical routine in non-invasive liver function evaluation].
    Eriksson S
    Lakartidningen; 1985 Oct; 82(44):3774-6. PubMed ID: 4068835
    [No Abstract]   [Full Text] [Related]  

  • 12. [Breath test with C 14-labeled aminopyrine in the study of hepatic function].
    Rocca F; Musazzi R; Reguzzoni G; Colombo W
    Recenti Prog Med; 1981 Apr; 70(4):409-17. PubMed ID: 7020006
    [No Abstract]   [Full Text] [Related]  

  • 13. [Measurement of hepatic function and short-term prognosis of hepatic diseases].
    Rueff B
    Gastroenterol Clin Biol; 1985 Dec; 9(12):867-70. PubMed ID: 3830799
    [No Abstract]   [Full Text] [Related]  

  • 14. [The antipyrine test: its 35-year history and prospects].
    Hartleb M; Kacperek T
    Wiad Lek; 1987 Nov; 40(21):1495-500. PubMed ID: 3330357
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-invasive assessment of liver function: trying not to miss an opportunity.
    Giannini EG; Testa R
    Aliment Pharmacol Ther; 2004 Apr; 19(7):827-8. PubMed ID: 15043524
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pathological breakdown of the two-color dye tests in participation of the liver in non-liver disease occurrences].
    Bargon G; Hochmiller C
    Acta Hepatosplenol; 1966; 13(4):201-7. PubMed ID: 5987791
    [No Abstract]   [Full Text] [Related]  

  • 17. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.
    Mahmoud M; Abdel-Kader R; Hassanein M; Saleh S; Botros S
    Eur J Pharmacol; 2007 Aug; 569(3):222-7. PubMed ID: 17628532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent findings on the morphology, function and physiopathology of the senile liver and on the hepato-portal circulation in the aged].
    Ruol A
    G Gerontol; 1967 Sep; 15(9):1059-88. PubMed ID: 5608322
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessing liver function.
    Sakka SG
    Curr Opin Crit Care; 2007 Apr; 13(2):207-14. PubMed ID: 17327744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study.
    Lotterer E; Högel J; Gaus W; Fleig WE; Bircher J
    Hepatology; 1997 Dec; 26(6):1426-33. PubMed ID: 9397982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.